The global patient engagement solutions market size accounted for USD 26.36 billion in 2025 and is forecasted to hit around USD 89.26 billion by 2034, representing a CAGR of 14.59% from 2025 to 2034. The North America market size was estimated at USD 9.15 billion in 2024 and is expanding at a CAGR of 17.89% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Functionality Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Patient Engagement Solutions Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Patient Engagement Solutions Market, by Delivery Type
8.1.1. Web-based/Cloud-based
8.1.1.1. Market Revenue and Forecast
8.1.2. On-premise
8.1.2.1. Market Revenue and Forecast
9.1. Patient Engagement Solutions Market, by Component Type
9.1.1. Software
9.1.1.1. Market Revenue and Forecast
9.1.2. Services
9.1.2.1. Market Revenue and Forecast
9.1.3. Hardware
9.1.3.1. Market Revenue and Forecast
10.1. Patient Engagement Solutions Market, by End Use Type
10.1.1. Payers
10.1.1.1. Market Revenue and Forecast
10.1.2. Providers
10.1.2.1. Market Revenue and Forecast
10.1.3. Individual Users
10.1.3.1. Market Revenue and Forecast
11.1. Patient Engagement Solutions Market, by Application Type
11.1.1. Social Management
11.1.1.1. Market Revenue and Forecast
11.1.2. Health Management
11.1.2.1. Market Revenue and Forecast
11.1.3. Home Healthcare Management
11.1.3.1. Market Revenue and Forecast
11.1.4. Financial Health Management
11.1.4.1. Market Revenue and Forecast
12.1. Patient Engagement Solutions Market, by Therapeutic Area
12.1.1. Chronic Diseases
12.1.1.1. Market Revenue and Forecast
12.1.2. Fitness
12.1.2.1. Market Revenue and Forecast
12.1.3. Women’s Health
12.1.3.1. Market Revenue and Forecast
12.1.4. Mental Health
12.1.4.1. Market Revenue and Forecast
12.1.5. Others
12.1.5.1. Market Revenue and Forecast
13.1. Patient Engagement Solutions Market, by Component Type
13.1.1. Communication
13.1.1.1. Market Revenue and Forecast
13.1.2. Health Tracking & Insights
13.1.2.1. Market Revenue and Forecast
13.1.3. Billing & Payments
13.1.3.1. Market Revenue and Forecast
13.1.4. Administrative
13.1.4.1. Market Revenue and Forecast
13.1.5. Patient Education
13.1.5.1. Market Revenue and Forecast
13.1.6. Others
13.1.6.1. Market Revenue and Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Delivery
14.1.2. Market Revenue and Forecast, by Component
14.1.3. Market Revenue and Forecast, by End Use
14.1.4. Market Revenue and Forecast, by Application
14.1.5. Market Revenue and Forecast, by Therapeutic Area
14.1.6. Market Revenue and Forecast, by Functionality
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Delivery
14.1.7.2. Market Revenue and Forecast, by Component
14.1.7.3. Market Revenue and Forecast, by End Use
14.1.7.4. Market Revenue and Forecast, by Application
14.1.8. Market Revenue and Forecast, by Therapeutic Area
14.1.8.1. Market Revenue and Forecast, by Functionality
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Delivery
14.1.9.2. Market Revenue and Forecast, by Component
14.1.9.3. Market Revenue and Forecast, by End Use
14.1.9.4. Market Revenue and Forecast, by Application
14.1.10. Market Revenue and Forecast, by Therapeutic Area
14.1.11. Market Revenue and Forecast, by Functionality
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Delivery
14.2.2. Market Revenue and Forecast, by Component
14.2.3. Market Revenue and Forecast, by End Use
14.2.4. Market Revenue and Forecast, by Application
14.2.5. Market Revenue and Forecast, by Therapeutic Area
14.2.6. Market Revenue and Forecast, by Functionality
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Delivery
14.2.8.2. Market Revenue and Forecast, by Component
14.2.8.3. Market Revenue and Forecast, by End Use
14.2.9. Market Revenue and Forecast, by Application
14.2.10. Market Revenue and Forecast, by Therapeutic Area
14.2.10.1. Market Revenue and Forecast, by Functionality
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Delivery
14.2.11.2. Market Revenue and Forecast, by Component
14.2.11.3. Market Revenue and Forecast, by End Use
14.2.12. Market Revenue and Forecast, by Application
14.2.13. Market Revenue and Forecast, by Therapeutic Area
14.2.14. Market Revenue and Forecast, by Functionality
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Delivery
14.2.15.2. Market Revenue and Forecast, by Component
14.2.15.3. Market Revenue and Forecast, by End Use
14.2.15.4. Market Revenue and Forecast, by Application
14.2.16. Market Revenue and Forecast, by Therapeutic Area
14.2.16.1. Market Revenue and Forecast, by Functionality
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Delivery
14.2.17.2. Market Revenue and Forecast, by Component
14.2.17.3. Market Revenue and Forecast, by End Use
14.2.17.4. Market Revenue and Forecast, by Application
14.2.18. Market Revenue and Forecast, by Therapeutic Area
14.2.18.1. Market Revenue and Forecast, by Functionality
14.3. APAC
14.3.1. Market Revenue and Forecast, by Delivery
14.3.2. Market Revenue and Forecast, by Component
14.3.3. Market Revenue and Forecast, by End Use
14.3.4. Market Revenue and Forecast, by Application
14.3.5. Market Revenue and Forecast, by Therapeutic Area
14.3.6. Market Revenue and Forecast, by Functionality
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Delivery
14.3.7.2. Market Revenue and Forecast, by Component
14.3.7.3. Market Revenue and Forecast, by End Use
14.3.7.4. Market Revenue and Forecast, by Application
14.3.8. Market Revenue and Forecast, by Therapeutic Area
14.3.9. Market Revenue and Forecast, by Functionality
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Delivery
14.3.10.2. Market Revenue and Forecast, by Component
14.3.10.3. Market Revenue and Forecast, by End Use
14.3.10.4. Market Revenue and Forecast, by Application
14.3.11. Market Revenue and Forecast, by Therapeutic Area
14.3.11.1. Market Revenue and Forecast, by Functionality
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Delivery
14.3.12.2. Market Revenue and Forecast, by Component
14.3.12.3. Market Revenue and Forecast, by End Use
14.3.12.4. Market Revenue and Forecast, by Application
14.3.12.5. Market Revenue and Forecast, by Therapeutic Area
14.3.12.6. Market Revenue and Forecast, by Functionality
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Delivery
14.3.13.2. Market Revenue and Forecast, by Component
14.3.13.3. Market Revenue and Forecast, by End Use
14.3.13.4. Market Revenue and Forecast, by Application
14.3.13.5. Market Revenue and Forecast, by Therapeutic Area
14.3.13.6. Market Revenue and Forecast, by Functionality
14.4. MEA
14.4.1. Market Revenue and Forecast, by Delivery
14.4.2. Market Revenue and Forecast, by Component
14.4.3. Market Revenue and Forecast, by End Use
14.4.4. Market Revenue and Forecast, by Application
14.4.5. Market Revenue and Forecast, by Therapeutic Area
14.4.6. Market Revenue and Forecast, by Functionality
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Delivery
14.4.7.2. Market Revenue and Forecast, by Component
14.4.7.3. Market Revenue and Forecast, by End Use
14.4.7.4. Market Revenue and Forecast, by Application
14.4.8. Market Revenue and Forecast, by Therapeutic Area
14.4.9. Market Revenue and Forecast, by Functionality
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Delivery
14.4.10.2. Market Revenue and Forecast, by Component
14.4.10.3. Market Revenue and Forecast, by End Use
14.4.10.4. Market Revenue and Forecast, by Application
14.4.11. Market Revenue and Forecast, by Therapeutic Area
14.4.12. Market Revenue and Forecast, by Functionality
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Delivery
14.4.13.2. Market Revenue and Forecast, by Component
14.4.13.3. Market Revenue and Forecast, by End Use
14.4.13.4. Market Revenue and Forecast, by Application
14.4.13.5. Market Revenue and Forecast, by Therapeutic Area
14.4.13.6. Market Revenue and Forecast, by Functionality
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Delivery
14.4.14.2. Market Revenue and Forecast, by Component
14.4.14.3. Market Revenue and Forecast, by End Use
14.4.14.4. Market Revenue and Forecast, by Application
14.4.14.5. Market Revenue and Forecast, by Therapeutic Area
14.4.14.6. Market Revenue and Forecast, by Functionality
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Delivery
14.5.2. Market Revenue and Forecast, by Component
14.5.3. Market Revenue and Forecast, by End Use
14.5.4. Market Revenue and Forecast, by Application
14.5.5. Market Revenue and Forecast, by Therapeutic Area
14.5.6. Market Revenue and Forecast, by Functionality
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Delivery
14.5.7.2. Market Revenue and Forecast, by Component
14.5.7.3. Market Revenue and Forecast, by End Use
14.5.7.4. Market Revenue and Forecast, by Application
14.5.8. Market Revenue and Forecast, by Therapeutic Area
14.5.8.1. Market Revenue and Forecast, by Functionality
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Delivery
14.5.9.2. Market Revenue and Forecast, by Component
14.5.9.3. Market Revenue and Forecast, by End Use
14.5.9.4. Market Revenue and Forecast, by Application
14.5.9.5. Market Revenue and Forecast, by Therapeutic Area
14.5.9.6. Market Revenue and Forecast, by Functionality
15.1. McKesson Corporation
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Allscripts Healthcare Solutions
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Orion Health Ltd.
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. GetWellNetwork Inc.
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Cerner Corporation
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Medecision Inc.
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Phytel Inc.
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Athenahealth Inc.
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. YourCareUniverse Inc.
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Lincor Solutions Ltd.
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample